The present study was designed to synthesis potassium dicitro bismuthate (III) complex. The complex was characterized by infrared spectra, conductivity and elemental analysis of Bi. The effect of gastro protection was investigated for the prepared complex against HCl- ethanol induced ulcer in rats. The complex was administered to rats at 50 and 100 mg\kg doses orally before one hour of receiving 0.2ml of HCl- ethanol mixture to induce gastric ulcer. Sucralfate (100mg\ kg, orally) was used as standard drug. The severity of gastro mucosal damage induced by HCl-ethanol was analyzed in term of ulcer index value. Administration of potassium dicitro bismuthate (III) one hour before HCl-ethanol had significantly decreased ulcer index value when compared to saline treated group. Sucralfate (100mg\kg, orally) also produced a significant decrease in ulcer index when compared with the saline treated group. There was no significant difference between potassium dicitro bismuthate (III) and Sucralfate in degree of protection against ulcer. Thus it can be concluded that potassium dicitro bismuthate (III) has antiulcer activity in rats.
Table of Contents
1. Introduction
2. Materials and Methods
2.1 Preparation of Bismuth complex
2.2 Pharmaceutical study
2.3 Histological evaluation
2.4 Histopathological studies
2.5 Statistical analysis
3. Results and Discussion
3.1 A- Structure assignment
3.1.1 Fourier transform-infrared spectroscopy (FTIR)
3.2 B- Antiulcer activity of the complex
4. Conclusion
Research Objectives and Key Topics
The primary objective of this study is the synthesis and chemical characterization of a potassium dicitro bismuthate (III) complex, followed by an experimental evaluation of its anti-ulcerogenic efficacy in rats against HCl-ethanol induced gastric mucosal damage.
- Chemical synthesis and structural characterization (FTIR, molar conductivity, elemental analysis) of the bismuth complex.
- Evaluation of gastroprotective activity using an ulcer index model in experimental animals.
- Histopathological analysis of stomach tissue to determine the severity of mucosal lesions, congestion, and inflammation.
- Comparative analysis of the protective effects between the synthesized complex and the standard drug Sucralfate.
Excerpt from the Book
INTRODUCTION
The importance of citric acid (CA) in abiotic and biological systems has been well established over the years (Ali et al., 2008, Carla et al., 2008, Tselesh, 2008, Maria et al., 2008). The nature of the metal-citrate complex formed depends upon the nature of the metal, the pH of the solution, type of coordination bond and the stoichiometric ratio of metal to citric acid.
Citrate is an important biological ligand for metal ions. It is present at high concentration (ca. 200 mM) in blood plasma and forms strong complexes not only with natural metal ions such as CaII, MgII and FeIII, but also with ions of toxic (e.g. AlIII), ( Petrova et al., 2008) therapeutic (e.g. BiIII) and diagnostic (e.g. 67GaIII) importance.
Peptic ulcer, one of the most widespread disease, is believed to be due to imbalance between aggressive and protective factors (Alkofahi and Atta, 1999) in the stomach such as acid–pepsin secretion, mucosal barrier, mucous secretion, blood flow, cellular regeneration, prostaglandin, epidural growth factor (Govindarajan et al., 2006, Lima et al., 2006) bacterial products (Helicobacter pylori) and drugs (Peskar and Maricic,1998). The current medical treatment of peptic ulcer is generally based on the inhibition of gastric acid secretion by H2 as Omeprazol and antimuscarinics, as well as, the acid in depended therapy provided by Sucralfate and bismuth (Bighett et al., 2005). Potassium dicitro bismuthate (III) has a topical action in the upper gastrointestinal tract (Coghill and Shepherd, 1988) and it is commonly used to treat a variety gastrointestinal disorder (Lourence and Keith, 2008). Potassium dicitro bismuthate (III) precipitate (an active metabolite) when it is reaches the acidic environment of the stomach (Wagstaff et al ., 1988).
Summary of Chapters
Introduction: Provides the theoretical background on citric acid metal complexes and the pathophysiology of peptic ulcers, establishing the rationale for the study.
Materials and Methods: Details the chemical synthesis process of the bismuth complex and the experimental design involving rat models to test gastroprotective activity.
Results and Discussion: Presents the spectroscopic and analytical data confirming the complex structure and reports the significant reduction in ulcer index scores observed in treated rats.
Conclusion: Summarizes that the synthesized potassium dicitro bismuthate (III) complex exhibits potent anti-ulcer activity comparable to standard treatments.
Keywords
citric acid, bismuth complex, antigastric ulcer, Sucralfate, gastroprotection, HCl-ethanol, ulcer index, peptic ulcer, histopathology, bismuthate, pharmacology, mucosal defense, prostaglandin, gastric epithelium, antiulcerogenic.
Frequently Asked Questions
What is the core focus of this research paper?
The paper focuses on the synthesis of a specific potassium dicitro bismuthate (III) complex and testing its ability to protect the stomach lining against chemically induced ulcers.
What are the primary thematic fields covered?
The study bridges inorganic chemistry (synthesis and structural characterization) with pharmacological research (gastroprotection and histopathological evaluation).
What is the main research question?
The main question is whether the synthesized potassium dicitro bismuthate (III) complex effectively acts as an anti-ulcer agent and how its protective performance compares to established standard medications like Sucralfate.
Which scientific methods were employed?
The research used analytical methods like Fourier transform-infrared spectroscopy (FTIR) and molar conductivity for characterization, and in-vivo rat models combined with histopathological tissue analysis for pharmacological testing.
What topics are discussed in the main body?
The main body covers the methodology of complex preparation, the statistical analysis of ulcer index reduction, the histological scoring of stomach tissue damage, and the biochemical mechanism of gastroprotection.
Which keywords best characterize this work?
Key terms include citric acid, bismuth complex, antigastric ulcer, Sucralfate, and histopathology.
How was the ulcer severity measured in the study?
Ulcer severity was quantified using an ulcer index based on the physical measurement of lesion lengths in millimeters after the stomach was opened along the greater curvature.
What was the outcome regarding the bismuth complex's efficacy?
The study concluded that the complex significantly reduced ulcer scores compared to the saline control group, showing a percentage of protection that was statistically similar to the standard drug Sucralfate.
- Quote paper
- Amer Taqa (Author), 2011, Preparation of PotassiumDicitro Bismuthate Complex as Antigastric Ulcer, Munich, GRIN Verlag, https://www.grin.com/document/209691
